TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 59 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | -95.6% | 43,635 | -95.8% | 0.00% | – |
| Q4 2019 | $90,000 | +542.9% | 1,033,000 | +408.9% | 0.00% | – |
| Q3 2019 | $14,000 | – | 203,000 | -59.1% | 0.00% | – |
| Q2 2019 | $0 | – | 496,000 | +1109.8% | 0.00% | – |
| Q1 2019 | $0 | – | 41,000 | -99.2% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 5,000,000 | +400.0% | 0.00% | -100.0% |
| Q2 2017 | $1,073,000 | +467.7% | 1,000,000 | +478.0% | 0.00% | – |
| Q4 2016 | $189,000 | -95.2% | 173,000 | -94.8% | 0.00% | -100.0% |
| Q3 2016 | $3,949,000 | -69.3% | 3,310,000 | -67.8% | 0.01% | -73.8% |
| Q2 2016 | $12,863,000 | +146.7% | 10,265,000 | +156.1% | 0.04% | +133.3% |
| Q1 2016 | $5,215,000 | +1036.2% | 4,008,000 | +1263.3% | 0.02% | +1700.0% |
| Q4 2015 | $459,000 | +34.2% | 294,000 | +16.7% | 0.00% | 0.0% |
| Q3 2015 | $342,000 | -45.1% | 252,000 | -43.5% | 0.00% | -50.0% |
| Q2 2015 | $623,000 | -88.0% | 446,000 | -88.2% | 0.00% | -85.7% |
| Q4 2014 | $5,173,000 | +2.6% | 3,786,000 | -3.6% | 0.01% | 0.0% |
| Q3 2014 | $5,040,000 | -98.1% | 3,926,000 | +87.0% | 0.01% | -81.6% |
| Q2 2014 | $268,407,000 | +5.7% | 2,100,000 | +5.0% | 0.08% | -2.6% |
| Q1 2014 | $253,876,000 | +79485.0% | 2,000,000 | +566.7% | 0.08% | +7700.0% |
| Q4 2013 | $319,000 | +355.7% | 300,000 | +334.8% | 0.00% | 0.0% |
| Q4 2012 | $70,000 | – | 69,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|